Trial Profile
A Randomized, Open-label, Single Oral Dose, 2-way Crossover Clinical Trial to Compare Safety and Pharmacokinetic Characteristics of CKD-337 in Healthy Male Volunteers
Status:
Completed
Phase of Trial:
Phase I
Latest Information Update: 21 Dec 2017
Price :
$35
*
At a glance
- Drugs Atorvastatin/choline fenofibrate (Primary) ; Atorvastatin; Atorvastatin/fenofibrate; Fenofibrate
- Indications Dyslipidaemias
- Focus Pharmacokinetics
- Sponsors Chong Kun Dang
- 20 Nov 2017 New trial record